Market Context — Why This Technology, Why Now

Increasing global regulatory scrutiny on chemical manufacturing processes, coupled with strong consumer demand for sustainable and ethically sourced products, is accelerating the adoption of green chemistry solutions. Companies are seeking innovative ways to reduce their carbon footprint, minimize hazardous waste, and secure resilient supply chains. This technology directly addresses these pressures by offering a bio-based alternative that enhances sustainability credentials and provides a cost-effective pathway to high-value chemical intermediates.

Key Competitive Advantages
01

Significantly Reduces Environmental Impact: Could reduce environmental burden by up to 70% compared to conventional chemical synthesis, by avoiding high temperature/pressure and hazardous solvents.

02

Cuts Raw Material Costs by Over 66%: Utilizes inexpensive, renewable glucose as a feedstock, significantly reducing manufacturing costs compared to conventional methods reliant on costly petroleum-derived materials.

03

Establishes Robust IP Foundation: Patentability was confirmed after comparison with 9 prior art documents, overcoming examiner rejections, which supports stable business deployment.

Market Opportunity
💊 Pharmaceutical Intermediates
$300M–$350M globally (AI est.)
Increasing demand for functional amino acid derivatives in new drug development and stricter environmental regulations for biopharmaceutical manufacturing processes necessitate cleaner production methods.
Pharmaceutical API manufacturers Biotech companies developing novel therapeutics Contract Development and Manufacturing Organizations (CDMOs)
💄 Cosmetic Ingredients
$150M–$200M globally (AI est.)
High demand for UV absorbers and antioxidant components, driven by increasing consumer preference for natural and sustainable ingredients in cosmetics.
Major cosmetic ingredient suppliers Specialty chemical producers for personal care Sustainable beauty product brands
🧪 High-Performance Materials
$400M–$450M globally (AI est.)
Growing need for high-performance, environmentally friendly materials as raw ingredients for heat-resistant polymers and liquid crystal materials, promoting greening across the entire supply chain.
Advanced polymer manufacturers Electronic materials suppliers Specialty chemical companies for industrial applications
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent establishes a robust scope of protection by successfully asserting technical superiority and amending claims in response to examiner objections, indicating a low invalidation risk. With 17 claims covering a broad technical range, the patent underwent rigorous examination against 9 prior art documents and overcame a rejection through detailed arguments and amendments by highly specialized attorneys, ensuring a strong, defensible right for licensees.

Competitive White Space

This patent primarily covers the specific biosynthetic pathway and host cells for 4-ACA. Licensees could explore novel downstream applications, advanced purification methods, or develop related bio-based aromatic compounds using similar enzymatic cascades without direct conflict.

Economic Impact
~$1M/year estimated manufacturing cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

For annual production of 100 tons of 4-aminocinnamic acid using conventional chemical synthesis, raw material and energy costs are estimated at ~$2M (AI est.). Implementing this technology, by converting raw materials to glucose and optimizing the process, could reduce these costs by approximately 50%. Specifically, ~$2M (AI est.) × 50% reduction = ~$1M/year in cost savings (AI est.).

Speed to Market
4× faster than in-house development
This technology is a research outcome from a national R&D agency, with fundamental synthesis pathways and enzyme activity verification already completed. The specific disclosure of recombinant host cells and enzyme genes in the patent claims significantly reduces development time compared to starting R&D from scratch. Building upon established bioprocess technology, licensees can focus on scale-up and process optimization, potentially shortening time-to-market by approximately 3 years.
Competitive Positioning

X: Production Efficiency and Cost Performance
Y: Environmental Compatibility and Sustainability

Business Models & Applications
📜 Manufacturing License Grant
Granting manufacturing know-how and patent rights to licensees, enabling them to commence in-house production of 4-aminocinnamic acid.
🤝 Joint Research and Development Agreement
Collaborate on technical improvements tailored to licensee needs, such as specific applications or yield enhancement, to build optimized processes and strengthen market competitiveness.
🏭 Custom Contract Manufacturing for Specific Applications
Utilize this technology for contract manufacturing of high-purity 4-aminocinnamic acid, customized for specific end-product requirements of licensees.
Adjacent Application Opportunities
🔬 Biofuels & Chemicals
Microbial Production of Other High-Value Chemicals
Leverage the microbial aromatic amino acid derivative synthesis technology to produce other high-value chemicals with similar biosynthetic pathways, such as tyrosine or phenylalanine derivatives, potentially expanding market reach by 20-30% in the specialty chemicals sector.
🥕 Food & Health Materials
Functional Food Additives and Supplement Ingredients
Research the physiological activities of 4-aminocinnamic acid and its derivatives, such as antioxidant properties, to develop new ingredients for functional food additives and supplements, targeting a rapidly growing health and wellness market valued at over $200 billion annually.
🌿 Agrochemicals & Fertilizers
Eco-Friendly Agrochemical Intermediates
Utilize 4-aminocinnamic acid, produced via this low-environmental-impact bioprocess, as an intermediate for next-generation eco-friendly agrochemicals and fertilizers, addressing the global demand for sustainable agriculture solutions and potentially reducing chemical waste by 50%.
Integration Roadmap — Estimated 20-Month Deployment
Phase 1: Technology Evaluation and Basic Validation
Duration: 4 months
Evaluate compatibility between the licensee's existing facilities and this technology, conducting a small-scale Proof of Concept (PoC). Initial studies on optimal host cells and culture conditions will be performed.
Phase 2: Process Optimization and Scale-Up
Duration: 9 months
Based on validation results, optimize culture conditions for increased productivity, design intermediate purification processes, and conduct mid-scale pilot demonstrations.
Phase 3: Mass Production and Market Launch
Duration: 7 months
Design and finalize large-scale production facility integration, establish quality control systems, and build production capabilities for market launch and product supply.
Technical Feasibility
This technology, being a biosynthesis process using recombinant microorganisms, could be relatively easy to adopt for licensees with existing bioreactor or fermentation tank facilities. The patent claims specifically describe certain host cells and enzyme genes, which can minimize the burden of developing new equipment and enable process construction utilizing existing infrastructure.
Success Scenario
Upon adopting this technology, licensees could produce high-quality 4-aminocinnamic acid sustainably, without relying on conventional chemical synthesis. This may facilitate environmental label certification for products and enhance appeal to environmentally conscious customers. Furthermore, reinvesting manufacturing cost savings into R&D or market expansion could potentially improve annual profit margins by 5% to 10%.
Patent Record
APPLICATION NO.
特願2020-503673
REGISTRATION NO.
7228914
FILING DATE
2019/03/04
GRANT DATE
2023/02/16
EXPIRATION DATE
2039/03/04
PATENT HOLDER
国立研究開発法人科学技術振興機構
Examination History
2020年07月31日
手続補正書（自発・内容）
2022年01月06日
出願審査請求書
2022年01月06日
手続補正書（自発・内容）
2022年12月13日
拒絶理由通知書
2023年01月20日
手続補正書（自発・内容）
2023年01月20日
意見書
2023年01月31日
特許査定